Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | -.--% | -.--% | -.--% |
Apr. 19 | Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 13 | Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 11.72M 16.04M |
---|---|---|---|---|---|
Net income 2022 | -2M -2.74M | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net Debt 2022 | 34.57K 47.31K | Net Debt 2023 | 86.34K 118K | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.47
x | P/E ratio 2023 |
-41.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.64% |
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Bourgeois
CEO | Chief Executive Officer | - | 23-06-06 |
Amanda Boudreau
BRD | Director/Board Member | - | 23-06-06 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 8.68M | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.19B | |
+3.98% | 3.15B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- ORI Stock